Yijun Zheng | Medicine | Best Researcher Award

Mr. Yijun Zheng | Medicine | Best Researcher Award

The Second Hospital & Clinical Medical School, Lanzhou University | China

Dr. Zheng Yijun is a dedicated medical researcher currently pursuing a PhD in Surgery at Lanzhou University. With a strong focus on the pharmacological actions of traditional Chinese medicine in cancer treatment, particularly gastric cancer, he has contributed to multiple papers, including two independent SCI publications. Dr. Zheng also serves as a reviewer for high-impact journals like Frontiers in Medicine and International Journal of Clinical Practice. He is actively involved in projects funded by the National Natural Science Foundation of China and collaborates on key provincial research initiatives.

Professional profileđŸ‘€

Scopus

Strengths for the Awards✹

  • Strong Research Focus: Zheng has a clear focus on the prevention and treatment of gastric cancer through traditional Chinese medicine, a significant and relevant area of study in modern healthcare.

  • Academic Contributions: Zheng has independently authored two SCI papers, one of which has achieved a high citation rate, highlighting the impact of their work in the academic community.

  • Collaborative Research: Zheng has been involved in eight research projects, including two funded by the National Natural Science Foundation of China, which demonstrates involvement in high-impact research.

  • Peer Review Contributions: Serving as a reviewer for reputable journals such as SCI and Frontiers in Medicine showcases the recognition of Zheng’s expertise and their ability to contribute to the broader academic community.

  • Zheng Yijun demonstrates strong academic research in a promising and highly relevant field. With a focus on traditional Chinese medicine for cancer treatment, significant publications, and involvement in prestigious research projects, Zheng is well-positioned for consideration for the “Best Researcher Award.” However, expanding the breadth of their research network, increasing publication output, and gaining editorial experience would help to further solidify their candidacy for this award.

Education 🎓

Dr. Zheng is currently enrolled in the PhD program in Surgery at Lanzhou University. His academic journey is complemented by his extensive participation in research, including a review of Astragalus Polysaccharide’s pharmacological effects, published in Frontiers in Pharmacology. He has independently authored SCI papers that contribute to the field of traditional medicine’s role in cancer treatment.

Experience đŸ’Œ

Dr. Zheng has participated in over eight research projects, two of which were funded by the National Natural Science Foundation of China. His work spans across the investigation of gastric cancer treatment and the pharmacological effects of traditional Chinese medicine. Additionally, Dr. Zheng has served as a reviewer for multiple high-impact journals, solidifying his expertise and credibility in the field.

Research Interest On Medicine 🔬

Dr. Zheng’s primary research interest is in the prevention and treatment of gastric cancer through traditional Chinese medicine. His research aims to provide a theoretical foundation for incorporating traditional medicine in cancer therapy, with a specific focus on polysaccharides and their pharmacological actions in tumor treatment.

Award 🏆

Dr. Zheng is a nominee for the Best Researcher Award at the Forensic Scientist Awards, due to his significant contributions to the field of medical research, particularly in the application of traditional Chinese medicine for tumor treatment. His innovative work and high citation rate highlight his impact in medical research.

Publications 📚

  1. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. “A Review of the Pharmacological Action of Astragalus Polysaccharide.” Front Pharmacol. 2020 Mar 24; 11:349. Link

    • Cited by: 348 articles (SCI citation)

  2. Zheng Y, Zhang Y, Wang Z, Guo X, Zhang L, Zhang Y. “Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer.” Discov Oncol. 2025 Apr 24; 16(1):606. Link

    • Cited by: 98 articles (SCI citation)

Conclusion 🌍

Dr. Zheng Yijun is an emerging leader in the field of medical research, particularly in the application of traditional Chinese medicine for cancer treatment. His dedication to advancing the understanding of gastric cancer and its treatment methods has already resulted in significant publications and recognition. As a nominee for the Best Researcher Award, his future in medical research looks promising, with continued contributions to the development of effective cancer therapies.

Marta Wojcik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Marta Wojcik | Medicine | Best Researcher Award

Head of Veterinary Oncology lab | University of Live Sciences in Lublin | Poland

Dr. Marta WĂłjcik is the Head of the Veterinary Oncology Laboratory at the Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Poland. With a distinguished career in veterinary pathology, her research primarily focuses on liver diseases, especially the mechanisms leading to primary malignant tumors such as hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCA). Her work encompasses both experimental models and in vitro analyses, contributing significantly to the understanding of hepatocarcinogenesis.

Profile

Orcid

Scopus

Strengths for the Awards

  • Extensive Research Contributions:
    • Dr. WĂłjcik has a well-established research background, primarily focusing on veterinary oncology and liver diseases.
    • Her work in hepatocarcinogenesis, fibrosis, and liver disease mechanisms has both veterinary and human medicine implications.
    • Multiple research projects, including leading and participating in grants funded by the National Science Centre in Poland and the Polish Ministry of Science and Higher Education.
  • International Scientific Collaborations:
    • Ongoing collaboration with the National Research Council in Pisa, Italy on liver cancer and hepatocytes research.
    • Erasmus-funded research and teaching exchanges in Germany, Italy, and Hungary, demonstrating strong international networking.
  • Publication Record & Reviewer Role:
    • Publications in high-impact factor journals, indicating significant contributions to veterinary and medical research.
    • Peer reviewer for reputed journals, including Molecules, The American Journal of the Medicine Sciences, and Oncology Letters.
  • Academic Leadership & Teaching:
    • Head of the Veterinary Oncology Lab, indicating leadership in her field.
    • Supervisor of PhD students and mentor for undergraduate students in veterinary medicine.
    • Teaches advanced courses in Pathophysiology, Oncology, and Laboratory Animal Diseases, which strengthens her role in academia.

Education 🎓

Dr. Wójcik earned her Doctor of Veterinary Medicine (DVM) degree in 1996 from the Agricultural Academy in Lublin. She pursued her Ph.D. at the University of Life Sciences in Lublin, completing it in 2005 with a dissertation titled “Changes in the secretion of Ubiquinone Q10 and secretory parameters of bile in the course of experimental hepatic oxidative stress in sheep.” In 2019, she achieved habilitation with a thesis on the activity of oval stem cells and macrophages in primary hepatic cancer in humans and rats.

Experience 🏱

Beginning her career as a research fellow at the Department of Pathophysiology, University of Life Sciences in Lublin, from 1996 to 2005, Dr. WĂłjcik then served as an Assistant Professor at the Faculty of Veterinary Medicine until 2019. Since 2020, she has been an Associate Professor, leading the Veterinary Oncology Laboratory. Her international experience includes scholarships and teaching engagements in Germany, Italy, and Hungary, enhancing her global perspective in veterinary medicine.

Research Interests On Medicine 🔬

Dr. WĂłjcik’s research delves into the pathomechanisms of liver diseases, with a particular emphasis on cancer processes leading to primary malignant tumors. She utilizes experimental rat models and in vitro analyses to study hepatocarcinogenesis. Her recent work focuses on the influence of “trained” M1 macrophages on isolated neoplastic cells and the impact of nutraceuticals on HCC development.

Awards and Recognitions 🏆

Throughout her career, Dr. WĂłjcik has been recognized for her contributions to veterinary pathology and hepatology. She has secured funding from prestigious institutions, including the National Science Centre in Poland and the Polish Ministry of Science and Higher Education, to support her groundbreaking research projects.

Publications 📚

  1. A Moderate Intake of Beer Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat Diet (HFD)-Induced Mouse Model
    • Authors: Vornoli, A., Souid, A., Lazzari, B., Capra, E., Pozzo, L.
    • Publication Year: 2024
    • Citations: 0
  2. Liver Antioxidant Capacity and Steatosis in Laying Hens Exposed to Various Quantities of Lupin (Lupinus angustifolius) Seeds in the Diet
    • Authors: WĂłjcik, M., Grabowski, S., Jarosz, Ɓ.S., GruszczyƄski, K., Marek, A.
    • Publication Year: 2024
    • Citations: 1
  3. Growth Rate and Bone Hydroxyproline Concentration in Turkeys Fed with a Silage-Composed Diet Modified with Different Diet Cation–Anion Differences (Dcads)
    • Authors: WĂłjcik, M., Stachal, K., Burzec, M., GruszczyƄski, K., Korga-Plewko, A.
    • Publication Year: 2022
    • Citations: 0
  4. Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
    • Authors: Korga-Plewko, A., Michalczyk, M., Adamczuk, G., WĂłjcik, M., Dudka, J.
    • Publication Year: 2020
    • Citations: 22
  5. Relationship Between Mammary Blood Flow, Infrared Thermography and Ovine Placental Lactogen During the Periparturient Period in Ewes
    • Authors: Bobowiec, R., WĂłjcik, M., Milczak, A., Gregula-Kania, M., Tatarczak, J.
    • Publication Year: 2019
    • Citations: 1
  6. Influence of Proinflammatory Macrophages (M-1) on Proliferative Activity and PPAR Expression in Neoplastic Rat Hepatocytes In Vitro
    • Authors: WĂłjcik, M., Kosior-Korzecka, U., Plewik, M., Bobowiec, R.
    • Publication Year: 2019
    • Citations: 0
  7. Changes in Growth Hormone Secretion and Leptin Receptor mRNA Expression Under the Influence of Leptin and Adrenocorticotropin in Pituitary Cells of Early Weaned Ewe Lambs
    • Authors: Kosior-Korzecka, U., WĂłjcik, M., Longo, V., Patkowski, K., Gregula-Kania, M.
    • Publication Year: 2019
    • Citations: 5
  8. Expression of Receptor Interacting Protein 1 and Receptor Interacting Protein 3 Oval Cells in a Rat Model of Hepatocarcinogenesis
    • Authors: WĂłjcik, M., Bobowiec, R., Lisiecka, U., Úmiech, A.
    • Publication Year: 2018
    • Citations: 3
  9. Growth Rate and Acid-Base Balance in Turkeys Fed a Silage-Containing Diet Modified by Different Dietary Cation-Anion Difference
    • Authors: GruszczyƄski, K., Strobel, W., WĂłjcik, M., Wessely-Szponder, J., Bobowiec, R.
    • Publication Year: 2017
    • Citations: 1
  10. In Vitro Proinflammatory Polarization of Macrophages Isolated from Hepatocarcinogenic Stage in Humans and Rats
    • Authors: WĂłjcik, M., Wessely-Szponder, J., Cichoz-Lach, H., CeliƄski, K., Bobowiec, R.
    • Publication Year: 2016
    • Citations: 4

Conclusion 🔚

Dr. Marta WĂłjcik’s extensive education, diverse experience, and dedicated research have established her as a leading figure in veterinary pathology, particularly in the study of liver diseases and cancer processes. Her ongoing contributions continue to advance the understanding of hepatocarcinogenesis, benefiting both the scientific community and veterinary medicine.

Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Ms. Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Lecturer-Researcher | Rey Juan Carlos University | Spain

Silvia Di Bonaventura is a passionate researcher, professor, and social entrepreneur with a commitment to advancing scientific innovation. Her journey reflects an insatiable curiosity, strong leadership, and dedication to contributing to transformative projects in health and biomedicine. Fluent in five languages, she combines global perspectives with academic rigor and entrepreneurial vision to address complex challenges in research and healthcare.

Profile:

Strengths for the Awards:

  1. Academic Excellence:
    Silvia’s strong academic foundation includes degrees in Physiotherapy, Invasive Physiotherapy, and an ongoing PhD in Pain Research, coupled with a Master’s in Clinical Research at Harvard University, showcasing her commitment to scientific rigor and innovation.
  2. Research Contributions:
    Silvia has demonstrated significant contributions to pain research, with notable publications on neuromodulation and digital health interventions for chronic pain. Her work combines clinical relevance and innovative methodologies, emphasizing her potential to make lasting impacts in biomedicine.
  3. Global Collaborations:
    Her experiences as an Invited Researcher at Vrije Universiteit Brussels and Harvard Medical School reflect her ability to work on international research collaborations, contributing to the advancement of cutting-edge medical technologies.
  4. Entrepreneurial Leadership:
    As the CEO of Bei (a digital health app for fibromyalgia) and the Founder of PainCorp, Silvia has effectively bridged research with practical healthcare solutions, emphasizing her visionary approach and ability to create real-world impact.
  5. Awards and Recognitions:
    Silvia’s accolades, including the Banco Santander Scholarship, Young Emerging Leader 2022, and the Outstanding Leadership Award, highlight her dedication, leadership, and exceptional achievements in the field.
  6. Multilingual Communication Skills:
    Fluent in five languages, Silvia has the ability to collaborate and communicate effectively across diverse cultures, enhancing her research’s global reach and impact.

🎓Education 

  • Diploma in Computer Science (2009–2014)
    Instituto TĂ©cnico Industrial “IIS” – TE
  • Degree in Physiotherapy (2014–2018)
    Universidad Alfonso X El Sabio
  • Master’s Degree in Invasive Physiotherapy (2017–2018)
    Universidad Camilo José Cela
  • Master’s Degree in Clinical Research (2024–2024)
    Harvard University
  • PhD in Pain Research (2021–Present)
    Universidad Rey Juan Carlos

đŸ’ŒExperience 

  • Physiotherapist & Co-Director
    Clínica Gatzambide (2018–2022)
    Led a successful physiotherapy practice focused on personalized patient care.
  • Professor & Researcher
    Rey Juan Carlos University (2021–Present)
    Teaching and conducting groundbreaking research in pain management.
  • Invited Researcher
    Vrije Universiteit Brussels (2023) & Harvard Medical School (2024)
    Advanced research on neuromodulation and pain mechanisms.
  • Entrepreneurial Roles
    • CEO & Founder of Bei (2024–Present): Innovating solutions for fibromyalgia self-management.
    • President of PainCorp (2024–Present): Dedicated to pain research and treatment.
    • Research Fellow at Mit LinQ and Harvard (2024–Present): Driving forward collaborative research initiatives.

🔬Research Interests On Health Sciences

Silvia’s research centers on pain management, clinical research, neuromodulation, and digital health solutions. She is particularly focused on designing innovative interventions for chronic pain conditions such as fibromyalgia, combining scientific rigor with practical applications for patient care.

🏆Awards 

  • Top 15 Graduates in Spain (Physiotherapy Ranking)
  • Banco Santander Scholarship (Best Academic Record)
  • PI in Competitive Funding (Biomedicine Research)
  • Entrepreneurship Babson College Scholarship
  • Nova Talent Member
  • Young Emerging Leader ’22 (Korea World Summit)
  • Outstanding Leadership Award (Harbour Space University)

đŸ„‡Achievements & Certifications

  • Recognized as one of the Top 15 Graduates in Spain in Physiotherapy.
  • Awarded Banco Santander Scholarship for academic excellence.
  • Recipient of Babson College Entrepreneurship Scholarship for advancing digital health solutions.
  • Certified in Italian (Native), Spanish (C2), English (C1), French (B1), and Chinese (HSK2).

🌍Final Note

Silvia Di Bonaventura exemplifies a modern researcher blending academic excellence, global collaboration, and entrepreneurship. Through her multifaceted roles, she seeks to bridge the gap between research and real-world impact, paving the way for transformative solutions in healthcare.

Publication Top Note’s

“How Does Conditioned Pain Modulation Influence Motor Imagery Processes in Women with Fibromyalgia Syndrome? A Cross-Sectional Study Secondary Analysis”

  • Authors: VĂ­ctor Riquelme-Aguado, Silvia Di-Bonaventura, MarĂ­a Elena GonzĂĄlez-Álvarez, Alazne Zabarte-Del Campo, JosuĂ© FernĂĄndez-Carnero, Antonio Gil-Crujera, Francisco GĂłmez-Esquer, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2024

“The Link between Endogenous Pain Modulation Changes and Clinical Improvement in Fibromyalgia Syndrome: A Meta-Regression Analysis”

  • Authors: Kevin Pacheco-Barrios, Rafaela Machado Filardi, Luis Fernando GonzĂĄlez-GonzĂĄlez, Nayeon Park, Fernanda Queiroz Petrus, Alba Navarro-Flores, Silvia Di-Bonaventura, Luana Gola Alves, Fernanda Queiroz, Felipe Fregni
  • Journal: Biomedicines
  • Year: 2024

“Perceived Benefits and Limitations of a Psychoeducation Program for Patients with Fibromyalgia: An Interpretative Phenomenological Analysis”

  • Authors: Silvia Di-Bonaventura, RaĂșl Ferrer-Peña, JoaquĂ­n Pardo-Montero, JosuĂ© FernĂĄndez-Carnero, Roy La Touche
  • Journal: Frontiers in Psychology
  • Year: 2024

“Effectiveness of Biobehavioral Therapeutic Education in Chronic Low Back Pain Intensity and Disability: A Systematic Review”

  • Authors: David RuĂ­z-del RĂ­o, Roy La Touche, Gwendoline Giolito, Silvia Di-Bonaventura, MĂłnica Grande-Alonso, Álvaro Reina Varona
  • Journal: Journal of MOVE and Therapeutic Science
  • Year: 2024

“Can a Specific Biobehavioral-Based Therapeutic Education Program Lead to Changes in Pain Perception and Brain Plasticity Biomarkers in Chronic Pain Patients? A Study Protocol for a Randomized Clinical Trial”

  • Authors: Silvia Di Bonaventura, Stephen D. Ginsberg, JosuĂ© FernĂĄndez Carnero, RaĂșl Ferrer-Peña
  • Journal: PLOS ONE
  • Year: 2024

“Effect of Different Physical Therapy Interventions on Brain-Derived Neurotrophic Factor Levels in Chronic Musculoskeletal Pain Patients: A Systematic Review”

  • Authors: Silvia Di-Bonaventura, JosuĂ© FernĂĄndez-Carnero, Luis Matesanz-GarcĂ­a, Alberto Arribas-Romano, Andrea Polli, RaĂșl Ferrer-Peña
  • Journal: Life
  • Year: 2023